Replacement of cellular with acellular pertussis (aP) vaccines has considerably reduced the
systemic reactions observed with diphtheria-tetanus toxoids-pertussis vaccine but has not …

To overcome the limitations of the current pertussis vaccines, those of limited duration of
action and failure to induce direct killing of Bordetella pertussis, a synthetic scheme was …

Despite wide vaccination coverage with efficacious vaccines, pertussis is still not under
control in any country. Two types of vaccines are available for the primary vaccination series …

The aim of this assessor-blinded trial was to compare the immunogenicity and reactogenicity
of a candidate diphtheria, tetanus toxoids and acellular pertussis vaccine with reduced …

Background: Large injection site reactions commonly follow booster doses of diphtheria-
tetanus-acellular pertussis (DTaP) vaccines at 4–6 years of age. A vaccine with lower …

As aluminium in vaccines has been associated with the incidence of local side effects
occurring after vaccination, this observer-blind randomised clinical trial was designed to …

Objectives. To determine the reactogenicity and immunogenicity of a fourth dose of 2 three-
component acellular pertussis vaccines combined with diphtheria-tetanus-acellular …

Objectives The aim of this study was to compare the immunogenicity and reactogenicity of a
lower dose diphtheria, tetanus and pertussis vaccine (dTpa) with the recommended vaccine …

PURPOSE: Disease caused by Bordetella pertussis is increasingly being identified among
older children and adults in immunized populations, indicating a waning of the vaccine …

A trial to compare the reactogenicity and immunogenicity of a reduced antigen content
diphtheria–tetanus–acellular pertussis (dTpa) vaccine with diphtheria–tetanus–whole-cell …